In a report released today, Brandon Berman from Bank of America Securities maintained a Buy rating on Texas Capital Bancshares (TCBI – Research ...

Emerson and Aspen Technology, Inc.  ("AspenTech") today announced that they have reached an agreement under which Emerson will acquire all outstanding shares of common stock of AspenTech not already ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Despite rampant calls for members of Congress to refrain from active stock market investing while they are in office, members of both political parties remain routinely invested in the markets and re ...

Janney Montgomery Scott LLC cut its stake in shares of iShares J.P. Morgan USD Emerging Markets Bond ETF (NASDAQ:EMB – Free Report) by 0.9% during the fourth quarter, according to the company in ...

Tevogen Bio Holdings Inc., a clinical-stage biotech firm specializing in immunotherapy, discussed its advancements in artificial intelligence (AI) during the J.P. Morgan Healthcare Conference.

The J.P. Morgan Nasdaq Equity Premium Income ETF (JEPQ) is an exchange-traded fund that mostly invests in large cap equity. The fund is an actively-managed fund of US large-cap companies from the ...

In a report released today, Seth Seifman from J.P. Morgan maintained a Buy rating on RTX (RTX – Research Report), with a price target of ...

Kinder Morgan's (NYSE: KMI) dry spell has come to an end. The natural gas pipeline company had struggled to grow in recent years because of headwinds from expiring contracts. However, those ...

Kinder Morgan (KMI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Crossmark Global Holdings Inc. decreased its position in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 5.5% during ...

JPMorgan updated its outlook on Nasdaq OMX Group Inc. (NASDAQ:NDAQ), increasing the price target to $95 from the previous $88, while reaffirming an Overweight rating on the stock. Currently trading at ...